Back to Search Start Over

Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis.

Authors :
Manta FSN
Jacomasso T
Rampazzo RCP
Moreira SJM
Zahra NM
Cole ST
Avanzi C
Leal-Calvo T
Vasconcellos SEG
Suffys P
Ribeiro-Alves M
Krieger MA
Costa ADT
Moraes MO
Source :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Feb 18; Vol. 16 (2), pp. e0009850. Date of Electronic Publication: 2022 Feb 18 (Print Publication: 2022).
Publication Year :
2022

Abstract

Leprosy is a chronic dermato-neurological disease caused by Mycobacterium leprae, an obligate intracellular bacterium. Timely detection is a challenge in leprosy diagnosis, relying on clinical examination and trained health professionals. Furthermore, adequate care and transmission control depend on early and reliable pathogen detection. Here, we describe a qPCR test for routine diagnosis of leprosy-suspected patients. The reaction simultaneously amplifies two specific Mycobacterium leprae targets (16S rRNA and RLEP), and the human 18S rRNA gene as internal control. The limit of detection was estimated to be 2.29 copies of the M. leprae genome. Analytical specificity was evaluated using a panel of 20 other skin pathogenic microorganisms and Mycobacteria, showing no cross-reactivity. Intra- and inter-operator Cp variation was evaluated using dilution curves of M. leprae DNA or a synthetic gene, and no significant difference was observed between three operators in two different laboratories. The multiplex assay was evaluated using 97 patient samples with clinical and histopathological leprosy confirmation, displaying high diagnostic sensitivity (91%) and specificity (100%). Validation tests in an independent panel of 50 samples confirmed sensitivity and specificity of 97% and 98%, respectively. Importantly, assay performance remained stable for at least five months. Our results show that the newly developed multiplex qPCR effectively and specifically detects M. leprae DNA in skin samples, contributing to an efficient diagnosis that expedites the appropriate treatment.<br />Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: TJ and RdCPR were employed by IBMP at the time the manuscript was accepted. IBMP has commercial interest in the reactions described in the manuscript. IBMP had no participation in the present study’s design, data collection, analysis, interpretation, or writing of the report and decision to submit for publication.

Details

Language :
English
ISSN :
1935-2735
Volume :
16
Issue :
2
Database :
MEDLINE
Journal :
PLoS neglected tropical diseases
Publication Type :
Academic Journal
Accession number :
35180224
Full Text :
https://doi.org/10.1371/journal.pntd.0009850